These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31837341)
1. Elevated progranulin as a novel biomarker to predict poor prognosis in community-acquired pneumonia. Luo Q; He X; Zheng Y; Ning P; Xu Y; Yang D; Shang Y; Gao Z J Infect; 2020 Feb; 80(2):167-173. PubMed ID: 31837341 [TBL] [Abstract][Full Text] [Related]
2. Admission Pentraxin-3 Level Predicts Severity of Community-Acquired Pneumonia Independently of Etiology. Luo Q; He X; Ning P; Zheng Y; Yang D; Xu Y; Shang Y; Gao Z Proteomics Clin Appl; 2019 Jul; 13(4):e1800117. PubMed ID: 30557448 [TBL] [Abstract][Full Text] [Related]
3. Increased progranulin as an independent predictive biomarker for poor prognosis in sepsis. Shan Y; Zhang X; Zhou G; Ji X; Gu Y Cytokine; 2022 Jul; 155():155911. PubMed ID: 35597170 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department. Lee KR; Hong DY; Paik JH; Jung HM Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363461 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department]. Chen Y; Li C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403 [TBL] [Abstract][Full Text] [Related]
6. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study. Alan M; Grolimund E; Kutz A; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P; J Intern Med; 2015 Aug; 278(2):174-84. PubMed ID: 25529395 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort. Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department]. Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623 [TBL] [Abstract][Full Text] [Related]
9. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. Kolditz M; Höffken G; Martus P; Rohde G; Schütte H; Bals R; Suttorp N; Pletz MW; BMC Infect Dis; 2012 Apr; 12():90. PubMed ID: 22501026 [TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study. Feng CM; Wang XM; Li MD; Xu Z; Hua DX; Cheng JY; Zheng L; Zhao H; Fu L BMC Pulm Med; 2021 Dec; 21(1):393. PubMed ID: 34856971 [TBL] [Abstract][Full Text] [Related]
11. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia. Cerda-Mancillas MC; Santiago-Germán D; Andrade-Bravo B; Pedraza-Olivares F; Valenzo-Hernández F; Leaños-Miranda A; Isordia-Salas I Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575 [TBL] [Abstract][Full Text] [Related]
12. Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Frenzen FS; Kutschan U; Meiswinkel N; Schulte-Hubbert B; Ewig S; Kolditz M Clin Microbiol Infect; 2018 Mar; 24(3):306.e1-306.e6. PubMed ID: 28710027 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of serum albumin levels and respiratory rate for community-acquired pneumonia: A prospective, multi-center study. Zhao L; Bao J; Shang Y; Zhang Y; Yin L; Yu Y; Xie Y; Chen L; Zheng Y; Xu Y; Gao Z PLoS One; 2021; 16(3):e0248002. PubMed ID: 33662036 [TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524 [TBL] [Abstract][Full Text] [Related]
15. Developing the Pneumonia-Optimized Ratio for Community-acquired pneumonia: An easy, inexpensive and accurate prognostic biomarker. Cury VF; Antoniazzi LQ; Oliveira PHK; Borelli WV; Cunha SVD; Frison GC; Moretto EE; Seligman R PLoS One; 2021; 16(3):e0248897. PubMed ID: 33755711 [TBL] [Abstract][Full Text] [Related]
16. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB. Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297 [TBL] [Abstract][Full Text] [Related]
17. [Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia]. Chen L; Han XD; Li YL; Zhang CX; Xing XQ Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):228-235. PubMed ID: 32234181 [No Abstract] [Full Text] [Related]
18. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632 [TBL] [Abstract][Full Text] [Related]
19. Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia. Lee JH; Chung HJ; Kim K; Jo YH; Rhee JE; Kim YJ; Kang KW Am J Emerg Med; 2013 Jan; 31(1):72-9. PubMed ID: 22867824 [TBL] [Abstract][Full Text] [Related]
20. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]